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Abstract 
Neuronal damage in traumatic brain injury is caused by primary injury at the time of the 
event and also delayed processes following the injury. Alterations in ion homeostasis have been 
implicated for the occurrence of this progressive secondary injury cascade. Magnesium is one of 
the most important ions that affect many metabolism in the CNS. Magnesium (Mg2+) levels in 
the blood have been shown to be depressed for hours to days following head injury. The 
objective of this study is to define the relationship between levels of ionized magnesium 
concentration and severity of traumatic brain injury. Analysis of data was carried out through a 
retrospective review of medical records and based on a systematized database pertaining to 
patients with head injury treated in Neurosurgery ward Hasan Sadikin Hospital Bandung in 
March 2011– August 2011. A GCS score was assigned and blood sample was obtained within 24 
h upon presentation. Patients were grouped into three categories: Group 1 (GCS 14-15), Group 2 
(9-13) and Group 3(GCS<9), consisting of 18 patients each. There were 40 males and 14 females 
with average age of 32 years. Average levels of ionized Mg2+in Group 1 were 2.12 mg/dL, p=0.0, 
CI=0.27 (0.14–0.40 ), Group 2=1.84 mg/dL, p=0.0, CI=0.47 (0.34–0.60) and Group 3=1.65 mg/dL, 
p=0.0, CI=0.19 (0.06–0.32). The conclusion of this study is that decrease in the serum 
magnesium (Mg2+) concentration is considered to be related to the severity of the injury.  
 
Keywords: magnesium, traumatic brain injury 
 
Abbreviations used in this paper: CT = computerized tomography; TBI = traumatic brain injury; 
GCS = Glasgow Coma Scale; Mg2+= magnesium; NMDA = n-methyl-D aspartate 
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Hubungan antara Konsentrasi Magnesium dengan Tingkat Keparahan 
Cedera Otak Traumatik pada Pasien dengan Cedera Kepala 
 
 
 
Abstrak 
Kerusakan neuron pada cedera otak traumatik disebabkan oleh cedera primer pada saat kejadian dan 
juga proses kerusakan yang timbul setelah kejadian trauma. Perubahan dalam hemostasis ion akan 
menyebabkan progresivitas dari kaskade mekanisme cedera sekunder. Magnesium adalah salah satu ion 
yang berperan penting mempengaruhi berbagai metabolisme dalam susunan sistem saraf pusat. Kadar 
magnesium (Mg2+) dalam darah terbukti menurun beberapa jam sampai dengan hari sesudah terjadinya 
cedera otak traumatik. Tujuan penelitian ini adalah menentukan hubungan antara kadar ion magnesium 
dengan tingkat keparahan cedera otak traumatik. Analisis data retrospektif dilakukan berdasarkan rekam 
media pasien dengan diagnosis cedera kepala di bagian Bedah Saraf Rumah Sakit Hasan Sadikin Bandung 
selama 1 Maret–30 Agustus 2011. Pencatatan GCS dan pengambilan darah dalam 24 jam pertama. 
Pasien dikategorikan ke dalam tiga kelompok; Kelompok 1 (GCS 14-15), Kelompok 2 (9-13,) dan 
Kelompok 3 (GCS <9), yang masing – masing terdiri atas 18 pasien. Pasien terdiri atas 40 pria dan 14 
wanita dengan umur rata–rata 32 tahun. Rata-rata kadar ion Mg2+ dalam kelompok 1 adalah  2,12 
mg/dL, p=0,0, CI=0,27 (0,14–0,40), Kelompok 2= 1,84 mg/dL, p=0,0, CI = 0,47 (0,3–0,60,) dan 
Kelompok 3 = 1,65 mg/dL, p=0,0, CI = 0,19 (0,06–0,32). Kesimpulan penelitian adalah bahwa penurunan 
kadar magnesium (Mg2+) serum mempunyai korelasi yang signifikan dengan tingkat keparahan cedera 
otak traumatik. 
 
Kata kunci: magnesium, cedera otak traumatik 
. 
 
 
Introduction  
Traumatic brain injury (TBI) occurs 
when a sudden trauma causes damage 
to the brain. TBI affects people of all 
ages and manifests itself with high 
morbidity and mortality. Despite many 
studies on traumatic brain injury, few 
markers have been applicable to 
diagnose trauma at tissue concentration. 
Some of the neuronal damage in TBI is 
caused by primary or mechanical injury 
occurring at the time of the traumatic 
event. However, much of the damage 
also appears to involve secondary or 
delayed processes that are activated in 
the hours, days, or weeks following the 
injury.    Several     factors     have    been 
implicated in the occurrence of this 
progressive secondary injury cascade, 
including alterations in ion 
homeostasis.1-,4 
Magnesium ion is gaining 
increasing recognition as a critical factor 
in neuronal cell function. The finding 
that magnesium ions mediate the gate n-
methyl-D aspartate class of glutamate 
and the mitochondrial permeability 
transition pore has rekindled earlier 
enthusiasm for magnesium as an 
important regulator of central nervous 
system function.2-5 A number of studies 
have supported a role for the level of 
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free magnesium in the brain as an 
important factor in the development of 
secondary traumatic and ischemic brain 
injury. The administration of 
magnesium after experimental TBI is 
neuroprotective and attenuates 
neuromotor dysfunction and cell death 
in the injured cortex.2-5 
This study was undertaken to help 
address the significancy of magnesium 
in head injured patients. The  study 
population consisted of 54 patients 
divided into three groups: mild, 
moderate and severe head injured 
patients.  
 
 
Material and Methods 
 
Patient Population 
From March to August 2011, all 
head injured patients admitted to our 
institution, either diagnosed as mild, 
moderate or severe head injury caused 
by closed head injury, were examined 
and identified, and their medical records 
were retrospectively reviewed.  
This study examined 1) whether 
serum ionized Mg2+ concentrations are 
reduced by traumatic brain injury (TBI); 
2) whether the extent of reduction 
correlates with severity 
of trauma assessed by the Glasgow 
Coma Scale (GSC) score. 
 
Data Collection 
Inclusion criteria included patients 
between age 14 to 70 years with 
diagnosis of closed TBI treated in our 
department, whereas exclusion criteria 
were multiple trauma patients with AIS 
≥ 3, GCS 3 after resuscitation and 
without head CT scan. 
Patients’ demographic, clinical, and 
neuroimaging data, including age, sex, 
admission GCS score, severity of head 
injury, and concentration of serum 
ionized Mg2+ were collected. 
Colorimetric method using COBAS 
INTEGRA 400 PLUS was used to 
measure serum ionized Mg2+.  
 
Statistical Analysis 
Data were processed on a personal 
computer by using commercially 
available statistic software. The ANOVA 
test was used to compare severity of 
head injury and concentration of 
Magnesium in the blood. A probability 
value of less than 0.05 was considered 
statistically significant. 
 
 
Result and Discussion 
 
Result 
The average age of the 54 patients 
was 32 years  (ranging from 15 to 69 
years old) and 22.49% of these patients 
were female. Figure 1 shows the average 
Mg2+ value of each of these groups. The 
mild head injury group had average 2.12 
mg/dL, moderate head injury 1.84 
mg/dL and severe head injury 1.65 
mg/dL. Normal Mg2+ concentration is 
regarded about 1.8–3.0 mg/dL.  
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Figure 1. Average of Mg2+ Value in Each Group according to  
the Severity of Head Injury 
 
 
 
Table 1.  Statistical Analysis of Severity of Head Injury and  
                                     Mg2+ Value between All Three Groups 
 
ANOVA 
Magnesium_Level 
 Sum of  
Squares df 
Mean 
Square F Sig. 
Between Groups 2.035 2 1.018 26.510 .000 
Within Groups 1.958 51 .038   
Total 3.993 53    
 
 
After processing data using 
commercial software, we found that 
the p value and confidence interval in 
each group consisted of  Group 1 
p=0.0, CI =0.27 (0.14–0.40 ), Group 2 
p=0.0, CI =0.47 (0.34–0.60) and Group 3 
p=0.0, CI = 0.19 (0.06–0.32). This shows 
a  strong correlation between severity 
of head injury and Mg2+ value as 
shown on Table 1 and Table 2. 
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Table 2.  Statistical Analysis of Severity of Head Injury and  
                                     Mg2+ Value between All Three Groups 
 
Multiple Comparisons 
Magnesium Level 
LSD 
Head 
Injury 
Head 
Injury 
Mean 
Difference  Std. Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Mild Moderate .27611* .06531 .000 .1450 .4072 
Severe .47333* .06531 .000 .3422 .6044 
Moderate Mild -.27611* .06531 .000 -.4072 -.1450 
Severe .19722* .06531 .004 .0661 .3283 
Severe Mild -.47333* .06531 .000 -.6044 -.3422 
Moderate -.19722* .06531 .004 -.3283 -.0661 
*. The mean difference is significant at the 0.05 level. 
 
Discussion 
Magnesium is the major 
intracellular divalent cation. The 
concentration of magnesium in serum is 
closely regulated within the range of 
1.8–3.0 Mg2+/dL, of which 30% is 
protein-bound and another 15% is 
loosely attached to phosphate and other 
anions. Half of the 25 g (1.000 mmol) of 
total body magnesium is located in bone, 
only half of which is insoluble in the 
mineral phase.3,5,6 
Magnesium is one of the most 
important ions in the CNS as it is a 
cofactor for approximately 325 enzymes 
in cells and is required for all ATP-
consuming and producing reactions, 
including glycolysis, Krebs cycle activity 
and oxidative phosphorylation. 
Although this ion is localized primarily 
in the intracellular compartment, its 
presence in the extracellular 
compartment is also critical for its 
physiologic function and homeostatic 
functions, including regulation of 
neuromuscular and vascular tone, 
protein synthesis, DNA and RNA 
aggregation, maintenance of plasma 
membrane integrity and the 
noncompetitive blockade of the NMDA-
receptor channel, thereby acting as a 
calcium antagonist. Because of its 
involvement in a number of 
bioenergetics and biochemical activities, 
magnesium appears to play an 
important role in normal neuronal 
activity. Furthermore, magnesium also 
seems to block the activation of NO-
synthetase after cerebral injury and also 
acts as a potent antioxidant.2,4,6,7    
The pathophysiology of TBI occurs 
in two phases, a primary phase and a 
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secondary phase. During the primary 
phase, there is localized neuronal death 
at the site of impact as a direct 
consequence of the biomechanical injury. 
During this phase, there is a decrease in 
cerebral blood ﬂow, resulting in hypoxia 
and ischemia with an increase of brain 
oxidative metabolism. A shortage of 
glucose and an acute increase in energy 
demand results in anaerobic metabolism 
of glucose (hyper-glycolysis) and release 
of lactate. These exacerbate the effects of 
the primary physical insult. The primary 
phase activates the subsequent and 
irreversible secondary phase, with long-
term effects. During this secondary 
phase, several imbalances in the 
biochemical homeostatic pathways and 
factors contribute to the cascade of 
events resulting in irreversible neuronal 
degeneration and death, distal to the 
injured site. As shown on Figure 2, 
excitotoxicity with excessive release of 
glutamate occurs and causes an 
overstimulation of the postsynaptic 
NMDA receptors that control the ionic 
channels.  There is a failure of calcium 
homeostasis and a massive inﬂux of 
sodium, calcium, and water, with 
delayed calcium deregulation. Ischemia 
due to increased ICP in the primary 
phase also adversely affects the 
secondary phase.1,2,4,5,6,8 
Magnesium has an important role 
in homeostatic regulation of the 
pathways involved in the delayed 
secondary phase of brain injury. During 
normal physiological processes, 
magnesium is a non-competitive 
inhibitor of the NMDA receptors and it 
thereby regulates calcium inﬂux. 5,8,9 
Divalent ion metabolism (calcium, 
phosphorus, and magnesium) following 
injury has not been studied as 
extensively as that of the monovalent 
ions (sodium, potassium and chloride). 
Difficulty in demonstrating a role for 
magnesium in secondary injury after 
trauma has been that, unlike calcium, 
measurement of magnesium 
concentration has been technically 
difficult and the available techniques 
largely inadequate.2,4,5,12 
Several studies have also stated that 
experimental TBI causes an immediate 
substantial decline in brain intracellular 
free and total Mg2+ concentration that 
lasts for up to four days following TBI. 
Ionized and total Mg2+ has also been 
shown to be significantly lowered 
following TBI. In summary, studies have 
demonstrated that brain total and free 
magnesium concentration declines after 
trauma, with the intracellular free 
magnesium concentration falling by as 
much as 60 percent. Although the exact 
mechanism of action by which 
magnesium improves posttraumatic 
outcome is unknown, the fact that 
magnesium is a critical regulatory cation 
in such a large number of cellular 
functions dictates that any alteration in 
free ion concentration may have wide 
ranging consequences.2 
Vink et al demonstrated 70% 
decline of intracellular free Mg2+  in the 
cortex of  brain-injured rats within the 
first hour of injury, and non-recovery of 
the same over the next 3 hours.  
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Figure 2. Magnesium Cascade after TBI.  
  (1) Intracellular magnesium levels fall after injury, resulting in loss of the voltage block on the NMDA receptor channel, allowing 
calcium influx. (2) Magnesium is a necessary cofactor for glycolitic and oxidative enzymes, and a decrease in the available Mg2+ inhibits 
both gycolisis and (3) oxidative phophorylation. (4) In turn, there is a decrease in the production of ATP and an overall reduction in the 
cell’s bioenergetic state.8 
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They later demonstrated its correlation 
with functional outcome.7,11 From our 
study we found that serum Mg2+level 
correlated significantly with severity of 
head injury as compared in each group 
(p < 0,05). Mg2+value was also 
significantly much lower in severe head 
injury group than in the rest. This 
finding is consistently the same as many 
of the studies mentioned above.  
Trauma-induced decreases in brain 
magnesium have been associated with 
neurological motor dysfunction and 
restoration of magnesium homeostasis 
has therefore become a target for 
therapeutic interventions. Many studies 
have demonstrated that pre- or 
posttraumatic administration of 
magnesium chloride (Mg2+Cl2) or 
magnesium sulfate (Mg2+SO4) could 
restore brain free magnesium levels, 
attenuate brain edema, and improve 
both neurological and cognitive outcome 
in various models of experimental 
TBI.2,9,10 
In addition to its impact on the 
bioenergetic state, it has been proposed 
that Mg2+ plays a pivotal role in 
determining the extent of excitotoxic 
damage following TBI. This has been 
shown consistently in many studies 
before. 
 
 
Conclusion 
Decrease in the serum Mg2+ 
concentration is considered to be related 
to the severity of the injury. We 
recommend that Mg2+ levels can be used 
to represent biochemical changes in head 
trauma to represent the extent of the 
injury. Further studies are needed to 
prove the efficacy of magnesium and 
also its vital role for therapy. 
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